Vaccine and Treatment Evaluation Units (VTEU)

疫苗和治疗评估单位 (VTEU)

• 批准号: 10200480
• 负责人: HANA M EL SAHLY
• 金额: $ 592.17万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-13 至 2022-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10200480
• 关键词: 18 year old; 2019-nCoV; Adult; COVID-19; Evaluation; Infection; Location; Messenger RNA; Phase; Placebos; Randomized; Recording of previous events; Risk; Safety; Vaccine Clinical Trial; Vaccines; blind; immunogenicity; placebo controlled study

ABSTRACT This supplement request is for a Phase 3, randomized, stratified, observer-blind, placebo- controlled study to evaluate the efficacy, safety and immunogenicity, of mRNA-1273 vaccine compared to placebo in adults 18 years of age and older who have no known history of SARS- CoV-2 infection but whose locations or circumstances put them at appreciable risk of acquiring COVID-19 and/or SARS-CoV-2 infection. This request also relates to other COVID 19 activities.

摘要